MMN as a translational biomarker of psychosis: from bench-to-bedside-to-real-world community settings
Thursday, Sep 10, 2015 9:30-10:30 Hörsaal 3
Chair
Juanita Todd and Gregory Light
Contributions
- MMN as a highly sensitive measure of subtle changes in NMDAR-mediated glutamate transmission in mice
Steven Siegel - Structural and functional brain correlates of at-risk mental state
Ulrich Schall - MMN, cortisol, inflammation, and gray matter loss in individuals at clinical high risk for psychosis
Daniel Mathalon - The “Other Side” of translational biomarker development: taking MMN out of academic labs and into real-world settings to improve our understanding and treatment of psychosis
Gregory A. Light